SAM #RFQ-FDA-133845-133915

FDA Solicitation for Four Illumina MiSeq i100 Plus Genomic Sequencing Systems and Support Services

The U.S. Food and Drug Administration (FDA) Human Foods Program is seeking to procure advanced genomic sequencing systems to modernize its laboratory capabilities. - Government Buyer: - U.S. Food and Drug Administration (FDA), Human Foods Program - OEMs and Vendors: - Illumina (OEM) - Products/Services Requested: - Four (4) Illumina MiSeq i100 Plus desktop genomic sequencing systems or equal - Each system must include: - Embedded touchscreen monitor - On-instrument computer with integrated control software - Pre-installed DRAGEN Bio-IT secondary analysis pipelines - Initial reagent kits - 12-month comprehensive warranty (parts and labor) - Delivery to four FDA facilities (one system per site) - On-site installation by certified manufacturer technical personnel - System verification and hands-on training for 58 FDA researchers per site - Option for up to four additional years of preventative maintenance (including travel, labor, parts, consumables, and reagents) - Unique/Notable Requirements: - Brand name or equal to Illumina MiSeq i100 Plus and DRAGEN Bio-IT Platform - Systems must support proprietary flow cells, reagents, and software licenses - Compliance with FDA IT security standards - High-throughput, cost-effective, and rapid sequencing for food safety surveillance and regulatory compliance - Training and system validation for a large number of researchers at each site

Description

This acquisition is restricted to brand name or equal: Illumina MiSeq i100 Plus and Illumina DRAGENTM Bio-IT Platform because these systems will replace aging sequencers currently owned by the FDA. FDA needs continuity of maintaining the same sequencing methods, proprietary flow cells and reagents or equal, software licenses, and manufacturer-supported components necessary to operate mission driven project continuity.

1. Purpose

The purpose of this procurement is to acquire four (4) Illumina MiSeq i100 Plus desktop genomic sequencing systems to support the FDA’s Human Foods Program (HFP). These systems will replace aging sequencers currently in use and enable high-throughput, cost-effective, and rapid sequencing critical for food safety surveillance, regulatory compliance, and the development of novel genomic applications. The acquisition directly supports FDA's mission to enhance public health through timely detection and characterization of foodborne pathogens in regulated products.

View original listing